Commonwealth Equity Services LLC trimmed its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 46.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 231,954 shares of the pharmacy operator's stock after selling 199,943 shares during the quarter. Commonwealth Equity Services LLC's holdings in Walgreens Boots Alliance were worth $2,164,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently made changes to their positions in the company. First Financial Corp IN boosted its position in Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after acquiring an additional 885 shares during the last quarter. Golden State Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at about $26,000. Riverview Trust Co boosted its position in shares of Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,590 shares in the last quarter. Venturi Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the fourth quarter worth approximately $28,000. Finally, TD Private Client Wealth LLC increased its holdings in Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock worth $29,000 after purchasing an additional 3,208 shares in the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.
Walgreens Boots Alliance Stock Down 0.2 %
Shares of WBA stock traded down $0.02 on Monday, hitting $11.17. The stock had a trading volume of 10,050,165 shares, compared to its average volume of 20,976,550. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The business has a 50 day moving average of $10.80 and a 200 day moving average of $9.93. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $21.74. The stock has a market cap of $9.65 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the prior year, the firm posted $0.66 EPS. The firm's quarterly revenue was up 7.6% compared to the same quarter last year. As a group, analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
Analysts Set New Price Targets
Several analysts have recently commented on WBA shares. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Royal Bank of Canada lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Evercore ISI upped their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. StockNews.com began coverage on Walgreens Boots Alliance in a research note on Wednesday, March 26th. They issued a "hold" rating for the company. Finally, Bank of America upped their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research note on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $10.59.
Read Our Latest Stock Report on WBA
About Walgreens Boots Alliance
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
